论文部分内容阅读
目的对比观察尼莫地平注射液治疗急性脑梗死疗效。方法使用尼莫地平注射液静脉滴注治疗急性脑梗死60例,同时设低分子右旋糖酐组做对照组。结果治疗组有效率达95%,对照组有效率达73%。两组间有显著差异,P<0.05,治疗中观察发现仅有少数病人有短暂血压下降(调整滴速后缓解)、面部潮红、头痛等。结论由此我们认为使用尼莫地平静滴治疗早期脑梗死效果良好、安全可靠,是一种较为理想的脑缺血改善药物,值得推广使用。
Objective To compare the efficacy of nimodipine in the treatment of acute cerebral infarction. Methods Nimodipine injection was used to treat 60 cases of acute cerebral infarction. At the same time, low molecular dextran group was used as the control group. Results The effective rate was 95% in the treatment group and 73% in the control group. There was a significant difference between the two groups, P <0.05. During the treatment, only a few patients were found to have transient blood pressure drop (remission after adjusting drip rate), facial flushing and headache. Conclusion Therefore, we believe that the use of nimodipine in the treatment of early cerebral infarction with good effect, safe and reliable, is an ideal improvement of cerebral ischemia drugs, it is worth promoting the use of.